{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T01:47:55Z","timestamp":1794448075823,"version":"4.9.1"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T00:00:00Z","timestamp":1756771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T00:00:00Z","timestamp":1756771200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100016022","name":"Data Center of Management Science, National Natural Science Foundation of China - Peking University","doi-asserted-by":"publisher","award":["82173208"],"award-info":[{"award-number":["82173208"]}],"id":[{"id":"10.13039\/501100016022","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100016022","name":"Data Center of Management Science, National Natural Science Foundation of China - Peking University","doi-asserted-by":"publisher","award":["82473380"],"award-info":[{"award-number":["82473380"]}],"id":[{"id":"10.13039\/501100016022","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the Key Project of Science & Technology Development Fund of Tianjin Education Commission for Higher Education","award":["2022ZD064"],"award-info":[{"award-number":["2022ZD064"]}]},{"name":"the Scientific and Technological Projects of Tianjin","award":["24ZXZSSS00050"],"award-info":[{"award-number":["24ZXZSSS00050"]}]},{"name":"Tianjin Key Medical Discipline (Specialty) Constrction Project","award":["TJYXZDXK-010A"],"award-info":[{"award-number":["TJYXZDXK-010A"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EMBO Mol Med"],"published-print":{"date-parts":[[2025,10,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Resistance to epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitor (TKI) remains a critical clinical challenge in EGFR mutant lung adenocarcinoma (LUAD). Therefore, it is urgent to explore personalized treatment strategies based on distinct resistance mechanisms to reverse EGFR-TKI resistance. Herein, we found that HER2 S310F mutation contributes to third-generation EGFR-TKI resistance, driven by the accumulation of neurotransmitter 5-hydroxytryptamine (5-HT). Mechanistically, 5-HT interacted with 5-HT3 receptor, triggering calcium ion (Ca\n                    <jats:sup>2+<\/jats:sup>\n                    ) influx and subsequent activation of the Ca\n                    <jats:sup>2+<\/jats:sup>\n                    \/CAMKK2\/AMPK pathway. This pathway activation conferred ferroptosis resistance, thereby driving aumolertinib resistance. 5-HT3 receptor (HTR3) antagonists were pinpointed as potential agents for reversing aumolertinib resistance through drug library screening and transcriptomics analysis. We demonstrated that pharmacologically targeting 5-HT\/HTR3 signaling with the clinically approved HTR3 antagonist palonosetron effectively restores aumolertinib sensitivity. Importantly, we showed that elevated 5-HT levels in patient plasma play a potential role in predicting EGFR-TKI resistance. Our data highlight the critical role of 5-HT and ferroptosis in the development of aumolertinib resistance, and propose HTR3 antagonists as a novel combination therapy strategy for LUAD treatment with aumolertinib.\n                  <\/jats:p>","DOI":"10.1038\/s44321-025-00293-5","type":"journal-article","created":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T09:04:19Z","timestamp":1756803859000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["5-HT regulates resistance to aumolertinib by attenuating ferroptosis in lung adenocarcinoma"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2873-6768","authenticated-orcid":false,"given":"Yuanying","family":"Feng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuchao","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-0483-6737","authenticated-orcid":false,"given":"Ran","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7637-3538","authenticated-orcid":false,"given":"Wenchen","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenshuai","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-2096-6015","authenticated-orcid":false,"given":"Liwei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongqi","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-2417-5824","authenticated-orcid":false,"given":"Peng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3345-8005","authenticated-orcid":false,"given":"Hua","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,2]]},"reference":[{"issue":"22","key":"293_CR1","doi-asserted-by":"crossref","first-page":"9184","DOI":"10.1158\/0008-5472.CAN-08-2133","volume":"68","author":"G Alpini","year":"2008","unstructured":"Alpini G, Invernizzi P, Gaudio E, Venter J, Kopriva S, Bernuzzi F, Onori P, Franchitto A, Coufal M, Frampton G et al (2008) Serotonin metabolism is dysregulated in cholangiocarcinoma, which has implications for tumor growth. Cancer Res 68(22):9184\u20139193","journal-title":"Cancer Res"},{"issue":"8","key":"293_CR2","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nrd1468","volume":"3","author":"TT Ashburn","year":"2004","unstructured":"Ashburn TT, Thor KB (2004) Drug repositioning: identifying and developing new uses for existing drugs. Nat Rev Drug Discov 3(8):673\u2013683","journal-title":"Nat Rev Drug Discov"},{"issue":"3","key":"293_CR3","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung HYA, Ferlay J, Siegel RL, Soerjomataram I, Jemal A (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74(3):229\u2013263","journal-title":"CA Cancer J Clin"},{"issue":"7","key":"293_CR4","volume":"14","author":"LL Chen","year":"2024","unstructured":"Chen LL, Huang ST, Wu XX, He WL, Song M (2024) Serotonin signalling in cancer: emerging mechanisms and therapeutic opportunities. Clin Transl Med 14(7):e1750","journal-title":"Clin Transl Med"},{"issue":"23","key":"293_CR5","doi-asserted-by":"crossref","first-page":"14717","DOI":"10.3390\/ijms232314717","volume":"23","author":"X Chen","year":"2022","unstructured":"Chen X, Huang KL, Hu SQ, Lan G, Gan X, Gao SY, Deng Y, Hu JW, Li L, Hu B et al (2022) Integrated transcriptome and metabolome analysis reveals the regulatory mechanisms of FASN in granulosa cells. Int J Mol Sci 23(23):14717","journal-title":"Int J Mol Sci"},{"key":"293_CR6","doi-asserted-by":"crossref","first-page":"104295","DOI":"10.1016\/j.critrevonc.2024.104295","volume":"196","author":"A Ferro","year":"2024","unstructured":"Ferro A, Marinato GM, Mulargiu C, Marino M, Pasello G, Guarneri V, Bonanno L (2024) The study of primary and acquired resistance to first-line osimertinib to improve the outcome of EGFR-mutated advanced Non-small cell lung cancer patients: the challenge is open for new therapeutic strategies. Crit Rev Oncol Hematol 196:104295","journal-title":"Crit Rev Oncol Hematol"},{"key":"293_CR7","doi-asserted-by":"crossref","unstructured":"Guo W, Xing YD, Luo XM, Li FG, Ren MZ, Liang YM (2023) Reactive oxygen species: a crosslink between plant and human eukaryotic cell systems. Int J Mol Sci 24(17):13052","DOI":"10.3390\/ijms241713052"},{"issue":"1","key":"293_CR8","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-023-36399-y","volume":"14","author":"JJ Harding","year":"2023","unstructured":"Harding JJ, Piha-Paul SA, Shah RH, Murphy JJ, Cleary JM, Shapiro GI, Quinn DI, Bra\u00f1a I, Moreno V, Borad M et al (2023) Antitumour activity of neratinib in patients with HER2 -mutant advanced biliary tract cancers. Nat Commun 14(1):630","journal-title":"Nat Commun"},{"issue":"1","key":"293_CR9","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jtho.2019.09.006","volume":"15","author":"CC Hsu","year":"2020","unstructured":"Hsu CC, Liao BC, Liao WY, Markovets A, Stetson D, Thress K, Yang JCH (2020) Exon 16-skipping HER2 as a novel mechanism of osimertinib resistance in EGFR L858R\/T790M-positive non-small cell lung cancer. J Thorac Oncol 15(1):50\u201361","journal-title":"J Thorac Oncol"},{"issue":"9","key":"293_CR10","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1158\/0008-5472.CAN-21-0940","volume":"83","author":"N Ishiyama","year":"2023","unstructured":"Ishiyama N, O\u2019Connor M, Salomatov A, Romashko D, Thakur S, Mentes A, Hopkins JF, Frampton GM, Albacker LA, Kohlmann A et al (2023) Computational and functional analyses of HER2 mutations reveal allosteric activation mechanisms and altered pharmacologic effects. Cancer Res 83(9):1531\u20131542","journal-title":"Cancer Res"},{"issue":"7293","key":"293_CR11","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1038\/nature08991","volume":"464","author":"M Iwabu","year":"2010","unstructured":"Iwabu M, Yamauchi T, Okada-Iwabu M, Sato K, Nakagawa T, Funata M, Yamaguchi M, Namiki S, Nakayama R, Tabata M et al (2010) Adiponectin and AdipoR1 regulate PGC-1\u03b1 and mitochondria by Ca2+ and AMPK\/SIRT1. Nature 464(7293):1313\u20131319","journal-title":"Nature"},{"issue":"1","key":"293_CR12","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1053\/j.gastro.2017.03.008","volume":"153","author":"SH Jiang","year":"2017","unstructured":"Jiang SH, Li J, Dong FY, Yang JY, Liu DJ, Yang XM, Wang YH, Yang MW, Fu XL, Zhang XX et al (2017) Increased serotonin signaling contributes to the Warburg effect in pancreatic tumor cells under metabolic stress and promotes growth of pancreatic tumors in mice. Gastroenterology 153(1):277\u2013291.e219","journal-title":"Gastroenterology"},{"issue":"4","key":"293_CR13","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","volume":"22","author":"XJ Jiang","year":"2021","unstructured":"Jiang XJ, Stockwell BR, Conrad M (2021) Ferroptosis: mechanisms, biology and role in disease. Nat Rev Mol Cell Biol 22(4):266\u2013282","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"5","key":"293_CR14","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1002\/med.21666","volume":"40","author":"R Juza","year":"2020","unstructured":"Juza R, Vlcek P, Mezeiova E, Musilek K, Soukup O, Korabecny J (2020) Recent advances with 5-HT3 modulators for neuropsychiatric and gastrointestinal disorders. Med Res Rev 40(5):1593\u20131678","journal-title":"Med Res Rev"},{"issue":"1","key":"293_CR15","volume":"11","author":"K Kim","year":"2020","unstructured":"Kim K, Hu WH, Audenet F, Almassi N, Hanrahan AJ, Murray K, Bagrodia A, Wong N, Clinton TN, Dason S et al (2020) Modeling biological and genetic diversity in upper tract urothelial carcinoma with patient derived xenografts. Nat Commun 11(1):1975","journal-title":"Nat Commun"},{"issue":"8","key":"293_CR16","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1056\/NEJMoa044238","volume":"352","author":"S Kobayashi","year":"2005","unstructured":"Kobayashi S, Boggon TJ, Dayaram T, Janne PA, Kocher O, Meyerson M, Johnson BE, Eck MJ, Tenen DG, Halmos B (2005) Mutation and resistance of non-small-cell lung cancer to gefitinib. N Engl J Med 352(8):786\u2013792","journal-title":"N Engl J Med"},{"issue":"11","key":"293_CR17","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1136\/thx.2009.134353","volume":"65","author":"M Konigshoff","year":"2010","unstructured":"Konigshoff M, Dumitrascu R, Udalov S, Amarie OV, Reiter R, Grimminger F, Seeger W, Schermuly RT, Eickelberg O (2010) Increased expression of 5-hydroxytryptamine2A\/B receptors in idiopathic pulmonary fibrosis: a rationale for therapeutic intervention. Thorax 65(11):949\u2013955","journal-title":"Thorax"},{"issue":"7","key":"293_CR18","first-page":"890","volume":"9","author":"E Legchenko","year":"2024","unstructured":"Legchenko E, Chouvarine P, Qadri F, Specker E, Nazar\u00e9 M, Wesolowski R, Matthes S, Bader M, Hansmann G (2024) Novel tryptophan hydroxylase inhibitor TPT-001 reverses PAH, vascular remodeling, and proliferative-proinflammatory gene expression. Basic Transl Sci 9(7):890\u2013902","journal-title":"Basic Transl Sci"},{"issue":"4","key":"293_CR19","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1080\/15548627.2021.1962681","volume":"18","author":"A Li","year":"2021","unstructured":"Li A, Yi B, Han H, Yang S, Hu Z, Zheng L, Wang J, Liao Q, Zhang H (2021) Vitamin D-VDR (vitamin D receptor) regulates defective autophagy in renal tubular epithelial cell in streptozotocin-induced diabetic mice via the AMPK pathway. Autophagy 18(4):877\u2013890","journal-title":"Autophagy"},{"issue":"16","key":"293_CR20","doi-asserted-by":"crossref","first-page":"3305","DOI":"10.1038\/s41388-020-1217-4","volume":"39","author":"J Li","year":"2020","unstructured":"Li J, Pu T, Yin L, Li Q, Liao CP, Wu BJ (2020) MAOA-mediated reprogramming of stromal fibroblasts promotes prostate tumorigenesis and cancer stemness. Oncogene 39(16):3305\u20133321","journal-title":"Oncogene"},{"issue":"9","key":"293_CR21","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1158\/2326-6066.CIR-20-1043","volume":"9","author":"T Li","year":"2021","unstructured":"Li T, Fu B, Zhang X, Zhou YJ, Yang MD, Cao MR, Chen YX, Tan YY, Hu R (2021) Overproduction of gastrointestinal 5-HT promotes colitis-associated colorectal cancer progression via enhancing NLRP3 inflammasome activation. Cancer Immunol Res 9(9):1008\u20131023","journal-title":"Cancer Immunol Res"},{"issue":"6","key":"293_CR22","doi-asserted-by":"crossref","first-page":"e2204006","DOI":"10.1002\/advs.202204006","volume":"10","author":"D Liu","year":"2023","unstructured":"Liu D, Liang CH, Huang B, Zhuang X, Cui WW, Yang L, Yang YH, Zhang YD, Fu XL, Zhang XJ et al (2023) Tryptophan metabolism acts as a new anti-ferroptotic pathway to mediate tumor growth. Adv Sci 10(6):e2204006","journal-title":"Adv Sci"},{"issue":"8","key":"293_CR23","doi-asserted-by":"crossref","first-page":"3400","DOI":"10.1016\/j.apsb.2023.05.015","volume":"13","author":"H Liu","year":"2023","unstructured":"Liu H, Huang Q, Fan Y, Li B, Liu X, Hu C (2023) Dissecting the novel abilities of aripiprazole: the generation of anti-colorectal cancer effects by targeting G\u03b1q via HTR2B. Acta Pharm Sin B 13(8):3400\u20133413","journal-title":"Acta Pharm Sin B"},{"issue":"27","key":"293_CR24","doi-asserted-by":"crossref","first-page":"3162","DOI":"10.1200\/JCO.21.02641","volume":"40","author":"S Lu","year":"2022","unstructured":"Lu S, Dong X, Jian H, Chen J, Chen G, Sun Y, Ji Y, Wang Z, Shi J, Lu J et al (2022) AENEAS: a randomized phase III trial of aumolertinib versus gefitinib as first-line therapy for locally advanced or metastatic non-small-cell lung cancer with EGFR exon 19 deletion or L858R mutations. J Clin Oncol 40(27):3162\u20133171","journal-title":"J Clin Oncol"},{"issue":"3","key":"293_CR25","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.pharmthera.2011.02.003","volume":"130","author":"TK Machu","year":"2011","unstructured":"Machu TK (2011) Therapeutics of 5-HT receptor antagonists: current uses and future directions. Pharmacol Ther 130(3):338\u2013347","journal-title":"Pharmacol Ther"},{"issue":"6","key":"293_CR26","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.molcel.2020.04.017","volume":"78","author":"S Marchi","year":"2020","unstructured":"Marchi S, Giorgi C, Galluzzi L, Pinton P (2020) Ca2+ fluxes and cancer. Mol Cell 78(6):1055\u20131069","journal-title":"Mol Cell"},{"key":"293_CR27","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.pharmthera.2015.01.009","volume":"150","author":"JD McCorvy","year":"2015","unstructured":"McCorvy JD, Roth BL (2015) Structure and function of serotonin G protein-coupled receptors. Pharmacol Ther 150:129\u2013142","journal-title":"Pharmacol Ther"},{"issue":"7","key":"293_CR28","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1111\/all.14748","volume":"76","author":"E Mendez-Enriquez","year":"2021","unstructured":"Mendez-Enriquez E, Alvarado-Vazquez PA, Abma W, Simonson OE, Rodin S, Feyerabend TB, Rodewald HR, Malinovschi A, Janson C, Adner M et al (2021) Mast cell-derived serotonin enhances methacholine-induced airway hyperresponsiveness in house dust mite-induced experimental asthma. Allergy 76(7):2057\u20132069","journal-title":"Allergy"},{"issue":"2","key":"293_CR29","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1124\/jpet.123.001644","volume":"386","author":"G Minotti","year":"2023","unstructured":"Minotti G (2023) All eyes on me, please: ocular palonosetron for the cancer patient with nausea and vomiting. J Pharmacol Exp Ther 386(2):111\u2013114","journal-title":"J Pharmacol Exp Ther"},{"issue":"7","key":"293_CR30","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1056\/NEJMoa1612674","volume":"376","author":"TS Mok","year":"2017","unstructured":"Mok TS, Wu Y-L, Ahn M-J, Garassino MC, Kim HR, Ramalingam SS, Shepherd FA, He Y, Akamatsu H, Theelen WSME et al (2017) Osimertinib or platinum\u2013pemetrexed in EGFR T790M\u2013positive lung cancer. N Engl J Med 376(7):629\u2013640","journal-title":"N Engl J Med"},{"issue":"3","key":"293_CR31","doi-asserted-by":"crossref","first-page":"2965","DOI":"10.3390\/ijms24032965","volume":"24","author":"J Nikoli\u0107","year":"2023","unstructured":"Nikoli\u0107 J, Vukojevi\u0107 K, \u0160olji\u0107 V, Mi\u0161kovi\u0107 J, Orlovi\u0107 Vlaho M, Saraga-Babi\u0107 M, Filipovi\u0107 N (2023) Expression patterns of serotonin receptors 5-HT1A, 5-HT2A, and 5-HT3A during human fetal lung development. Int J Mol Sci 24(3):2965","journal-title":"Int J Mol Sci"},{"issue":"21","key":"293_CR32","doi-asserted-by":"crossref","first-page":"8004","DOI":"10.1002\/cam4.3434","volume":"9","author":"YY Pang","year":"2020","unstructured":"Pang YY, Li JD, Gao L, Yang X, Dang YW, Lai ZF, Liu LM, Yang J, Wu HY, He RQ et al (2020) The clinical value and potential molecular mechanism of the downregulation of MAOA in hepatocellular carcinoma tissues. Cancer Med 9(21):8004\u20138019","journal-title":"Cancer Med"},{"issue":"2","key":"293_CR33","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S1470-2045(10)70087-5","volume":"12","author":"W Pao","year":"2011","unstructured":"Pao W, Girard N (2011) New driver mutations in non-small-cell lung cancer. Lancet Oncol 12(2):175\u2013180","journal-title":"Lancet Oncol"},{"issue":"2","key":"293_CR34","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1002\/jcb.29395","volume":"121","author":"M Rashidi","year":"2019","unstructured":"Rashidi M, Bazi A, Shiran MR, Bagheri A, Mehrabadi AR, Kalantar H, Ghafouri Z, Hosseini SM (2019) Tropisetron attenuates tumor growth and progression in an experimental model of mouse lung cancer. J Cell Biochem 121(2):1610\u20131622","journal-title":"J Cell Biochem"},{"issue":"1","key":"293_CR35","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/s42003-024-05996-y","volume":"7","author":"RB Renden","year":"2024","unstructured":"Renden RB, Institoris A, Sharma K, Tran CH (2024) Modulatory effects of noradrenergic and serotonergic signaling pathway on neurovascular coupling. Commun Biol 7(1):287","journal-title":"Commun Biol"},{"issue":"1","key":"293_CR36","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-023-41536-8","volume":"14","author":"G Renga","year":"2023","unstructured":"Renga G, D\u2019Onofrio F, Pariano M, Galarini R, Barola C, Stincardini C, Bellet MM, Ellemunter H, Lass-Floerl C, Costantini C et al (2023) Bridging of host-microbiota tryptophan partitioning by the serotonin pathway in fungal pneumonia. Nat Commun 14(1):5753","journal-title":"Nat Commun"},{"key":"293_CR37","doi-asserted-by":"crossref","first-page":"101256","DOI":"10.1016\/j.arr.2021.101256","volume":"66","author":"Y Santin","year":"2021","unstructured":"Santin Y, Resta J, Parini A, Mialet-Perez J (2021) Monoamine oxidases in age-associated diseases: New perspectives for old enzymes. Ageing Res Rev 66:101256","journal-title":"Ageing Res Rev"},{"key":"293_CR38","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.lungcan.2020.07.014","volume":"147","author":"S Schmid","year":"2020","unstructured":"Schmid S, Li JJN, Leighl NB (2020) Mechanisms of osimertinib resistance and emerging treatment options. Lung Cancer 147:123\u2013129","journal-title":"Lung Cancer"},{"issue":"5","key":"293_CR39","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1158\/1078-0432.CCR-19-1376","volume":"26","author":"R Shi","year":"2020","unstructured":"Shi R, Radulovich N, Ng C, Liu N, Notsuda H, Cabanero M, Martins-Filho SN, Raghavan V, Li Q, Mer AS et al (2020) Organoid cultures as preclinical models of non-small cell lung cancer. Clin Cancer Res 26(5):1162\u20131174","journal-title":"Clin Cancer Res"},{"issue":"4","key":"293_CR40","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1002\/hep.23441","volume":"51","author":"C Soll","year":"2010","unstructured":"Soll C, Jang JH, Riener MO, Moritz W, Wild PJ, Graf R, Clavien PA (2010) Serotonin promotes tumor growth in human hepatocellular cancer. Hepatology 51(4):1244\u20131254","journal-title":"Hepatology"},{"issue":"2","key":"293_CR41","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1056\/NEJMoa1713137","volume":"378","author":"JC Soria","year":"2018","unstructured":"Soria JC, Ohe Y, Vansteenkiste J, Reungwetwattana T, Chewaskulyong B, Lee KH, Dechaphunkul A, Imamura F, Nogami N, Kurata T et al (2018) Osimertinib in untreated-mutated advanced non-small-cell lung cancer. N Engl J Med 378(2):113\u2013125","journal-title":"N Engl J Med"},{"key":"293_CR42","doi-asserted-by":"crossref","first-page":"101899","DOI":"10.1016\/j.arr.2023.101899","volume":"87","author":"Y Sun","year":"2023","unstructured":"Sun Y, Yan C, He L, Xiang S, Wang P, Li Z, Chen Y, Zhao J, Yuan Y, Wang W et al (2023) Inhibition of ferroptosis through regulating neuronal calcium homeostasis: an emerging therapeutic target for Alzheimer\u2019s disease. Ageing Res Rev 87:101899","journal-title":"Ageing Res Rev"},{"key":"293_CR43","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ejca.2021.02.019","volume":"149","author":"K Tanaka","year":"2021","unstructured":"Tanaka K, Asahina H, Kishimoto J, Miyata Y, Uchida T, Watanabe K, Hamai K, Harada T, Tsubata Y, Sugawara S et al (2021) Original research osimertinib versus osimertinib plus chemotherapy for non-small cell lung cancer with EGFR (T790M)-associated resistance to initial EGFR inhibitor treatment: an open-label, randomised phase 2 clinical trial. Eur J Cancer 149:14\u201322","journal-title":"Eur J Cancer"},{"issue":"11","key":"293_CR44","doi-asserted-by":"crossref","first-page":"e0294236","DOI":"10.1371\/journal.pone.0294236","volume":"18","author":"DD Tang","year":"2023","unstructured":"Tang DD, Chen MJ, Huang XH, Zhang GC, Zeng L, Zhang GS, Wu SJ, Wang YW (2023) SRplot: a free online platform for data visualization and graphing. PLoS ONE 18(11):e0294236","journal-title":"PLoS ONE"},{"issue":"10","key":"293_CR45","doi-asserted-by":"crossref","first-page":"3953","DOI":"10.1111\/cas.14592","volume":"111","author":"M Tone","year":"2020","unstructured":"Tone M, Tahara S, Nojima S, Motooka D, Okuzaki D, Morii E (2020) HTR3A is correlated with unfavorable histology and promotes proliferation through ERK phosphorylation in lung adenocarcinoma. Cancer Sci 111(10):3953\u20133961","journal-title":"Cancer Sci"},{"issue":"23","key":"293_CR46","doi-asserted-by":"crossref","first-page":"3868","DOI":"10.1158\/0008-5472.CAN-23-1012","volume":"83","author":"RH Tu","year":"2023","unstructured":"Tu RH, Wu SZ, Huang ZN, Zhong Q, Ye YH, Zheng CH, Xie JW, Wang JB, Lin JX, Chen QY et al (2023) Neurotransmitter receptor HTR2B regulates lipid metabolism to inhibit ferroptosis in gastric cancer. Cancer Res 83(23):3868\u20133885","journal-title":"Cancer Res"},{"key":"293_CR47","doi-asserted-by":"crossref","first-page":"102488","DOI":"10.1016\/j.ctrv.2022.102488","volume":"112","author":"C Vaghi","year":"2023","unstructured":"Vaghi C, Mauri G, Agostara AG, Patelli G, Pizzutilo EG, Nakamura Y, Yoshino T, Siena S, Sartore-Bianchi A (2023) The predictive role of ERBB2 point mutations in metastatic colorectal cancer: a systematic review. Cancer Treat Rev 112:102488","journal-title":"Cancer Treat Rev"},{"issue":"7775","key":"293_CR48","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/s41586-019-1564-x","volume":"573","author":"V Venkataramani","year":"2019","unstructured":"Venkataramani V, Tanev DI, Strahle C, Studier-Fischer A, Fankhauser L, Kessler T, K\u00f6rber C, Kardorff M, Ratliff M, Xie R et al (2019) Glutamatergic synaptic input to glioma cells drives brain tumour progression. Nature 573(7775):532\u2013538","journal-title":"Nature"},{"issue":"1","key":"293_CR49","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jid.2021.05.025","volume":"142","author":"S Wang","year":"2022","unstructured":"Wang S, Yi X, Wu Z, Guo S, Dai W, Wang H, Shi Q, Zeng K, Guo W, Li C (2022) CAMKK2 defines ferroptosis sensitivity of melanoma cells by regulating AMPK\u2012NRF2 pathway. J Invest Dermatol 142(1):189\u2013200.e188","journal-title":"J Invest Dermatol"},{"issue":"1","key":"293_CR50","volume":"12","author":"YC Wang","year":"2021","unstructured":"Wang YC, Wang X, Yu J, Ma F, Li Z, Zhou Y, Zeng S, Ma X, Li YR, Neal A et al (2021) Targeting monoamine oxidase A-regulated tumor-associated macrophage polarization for cancer immunotherapy. Nat Commun 12(1):3530","journal-title":"Nat Commun"},{"issue":"5","key":"293_CR51","doi-asserted-by":"crossref","first-page":"799","DOI":"10.3390\/antiox11050799","volume":"11","author":"YY Wang","year":"2022","unstructured":"Wang YY, Ding YP, Sun PB, Zhang WQ, Xin QL, Wang NC, Niu YY, Chen Y, Luo JY, Lu JH et al (2022) Empagliflozin-enhanced antioxidant defense attenuates lipotoxicity and protects hepatocytes by promoting FoxO3a-and Nrf2-mediated nuclear translocation via the CAMKK2\/AMPK pathway. Antioxidants 11(5):799","journal-title":"Antioxidants"},{"issue":"5","key":"293_CR52","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1007\/s13402-023-00821-w","volume":"46","author":"YY Wang","year":"2023","unstructured":"Wang YY, Zhou YQ, Xie JX, Zhang X, Wang SC, Li Q, Hu LP, Jiang SH, Yi SQ, Xu J et al (2023) MAOA suppresses the growth of gastric cancer by interacting with NDRG1 and regulating the Warburg effect through the PI3K\/AKT\/mTOR pathway. Cell Oncol 46(5):1429\u20131444","journal-title":"Cell Oncol"},{"issue":"5","key":"293_CR53","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.molmed.2024.09.010","volume":"31","author":"J Wei","year":"2024","unstructured":"Wei J, Wu BJ (2024) Targeting monoamine oxidases in cancer: advances and opportunities. Trends Mol Med 31(5):479\u2013491","journal-title":"Trends Mol Med"},{"issue":"16","key":"293_CR54","doi-asserted-by":"crossref","first-page":"4275","DOI":"10.1158\/0008-5472.CAN-21-0198","volume":"81","author":"J Wei","year":"2021","unstructured":"Wei J, Yin L, Li J, Wang J, Pu T, Duan P, Lin TP, Gao AC, Wu BJ (2021) Bidirectional cross-talk between MAOA and AR promotes hormone-dependent and castration-resistant prostate cancer. Cancer Res 81(16):4275\u20134289","journal-title":"Cancer Res"},{"issue":"1","key":"293_CR55","volume":"17","author":"S-G Wu","year":"2018","unstructured":"Wu S-G, Shih J-Y (2018) Management of acquired resistance to EGFR TKI\u2013targeted therapy in advanced non-small cell lung cancer. Mol Cancer 17(1):38","journal-title":"Mol Cancer"},{"key":"293_CR56","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jare.2024.04.033","volume":"65","author":"Y Wu","year":"2024","unstructured":"Wu Y, Jia C, Liu W, Zhan W, Chen Y, Lu J, Bao Y, Wang S, Yu C, Zheng L et al (2024) Sodium citrate targeting Ca2+\/CAMKK2 pathway exhibits anti-tumor activity through inducing apoptosis and ferroptosis in ovarian cancer. J Adv Res 65:89\u2013104","journal-title":"J Adv Res"},{"issue":"4","key":"293_CR57","first-page":"3554","volume":"63","author":"ZQ Wu","year":"2024","unstructured":"Wu ZQ, Li JF, Zhong ML, Xu ZY, Yang ML, Xu CY (2024) HTR3A promotes non-small cell lung cancer through the FOXH1\/Wnt3A signaling pathway. Biochem Genet 63(4):3554\u20133566","journal-title":"Biochem Genet"},{"issue":"4","key":"293_CR58","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1210\/er.2018-00283","volume":"40","author":"JM Yabut","year":"2019","unstructured":"Yabut JM, Crane JD, Green AE, Keating DJ, Khan WI, Steinberg GR (2019) Emerging roles for serotonin in regulating metabolism: new implications for an ancient molecule. Endocr Rev 40(4):1092\u20131107","journal-title":"Endocr Rev"},{"issue":"1","key":"293_CR59","volume":"22","author":"C Yang","year":"2024","unstructured":"Yang C, Zhao X, Zhou WS, Li Q, Lazarovici P, Zheng WH (2024) Artemisinin conferred cytoprotection to human retinal pigment epithelial cells exposed to amiodarone-induced oxidative insult by activating the CaMKK2\/AMPK\/Nrf2 pathway. J Transl Med 22(1):844","journal-title":"J Transl Med"},{"issue":"1","key":"293_CR60","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/s41417-024-00843-y","volume":"32","author":"P Yue","year":"2025","unstructured":"Yue P, He Y, Zuo R, Gong W, Wang Y, Chen L, Luo Y, Feng Y, Gao Y, Liu Z et al (2025) CCDC34 maintains stemness phenotype through \u03b2-catenin-mediated autophagy and promotes EGFR-TKI resistance in lung adenocarcinoma. Cancer Gene Ther 32(1):104\u2013121","journal-title":"Cancer Gene Ther"},{"issue":"7775","key":"293_CR61","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/s41586-019-1576-6","volume":"573","author":"QQ Zeng","year":"2019","unstructured":"Zeng QQ, Michael IP, Zhang P, Saghafinia S, Knott G, Jiao W, McCabe BD, Galv\u00e1n JA, Robinson HPC, Zlobec I et al (2019) Synaptic proximity enables NMDAR signalling to promote brain metastasis. Nature 573(7775):526","journal-title":"Nature"},{"issue":"1","key":"293_CR62","volume":"21","author":"C Zhang","year":"2022","unstructured":"Zhang C, Liu XY, Jin SD, Chen Y, Guo RH (2022) Ferroptosis in cancer therapy: a novel approach to reversing drug resistance. Mol Cancer 21(1):47","journal-title":"Mol Cancer"},{"issue":"4","key":"293_CR63","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.21037\/tlcr-21-303","volume":"10","author":"T Zhang","year":"2021","unstructured":"Zhang T, Sun BB, Zhong CX, Xu K, Wang ZX, Hofman P, Nagano T, Legras A, Ricciuti B, Breadner D et al (2021) Targeting histone deacetylase enhances the therapeutic effect of Erastin-induced ferroptosis in EGFR-activating mutant lung adenocarcinoma. Transl Lung Cancer Res 10(4):1857\u20131872","journal-title":"Transl Lung Cancer Res"},{"issue":"3","key":"293_CR64","doi-asserted-by":"crossref","first-page":"e010555","DOI":"10.1136\/jitc-2024-010555","volume":"13","author":"Z Zhao","year":"2025","unstructured":"Zhao Z, Hu Y, Li H, Lu T, He X, Ma Y, Huang M, Li M, Yang L, Shi C (2025) Inhibition of stromal MAOA leading activation of WNT5A enhance prostate cancer immunotherapy by involving the transition of cancer-associated fibroblasts. J Immunother Cancer 13(3):e010555","journal-title":"J Immunother Cancer"},{"issue":"1","key":"293_CR65","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1186\/s13046-024-03202-9","volume":"43","author":"YY Zheng","year":"2024","unstructured":"Zheng YY, Li LF, Shen ZB, Wang LH, Niu XY, Wei YJ, Sun SL, Zhao J (2024) Mechanisms of neural infiltration-mediated tumor metabolic reprogramming impacting immunotherapy efficacy in non-small cell lung cancer. J Exp Clin Cancer Res 43(1):284","journal-title":"J Exp Clin Cancer Res"}],"container-title":["EMBO Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44321-025-00293-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1038\/s44321-025-00293-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44321-025-00293-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T10:28:00Z","timestamp":1786962480000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1038\/s44321-025-00293-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,2]]},"references-count":65,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10,10]]}},"alternative-id":["293"],"URL":"https:\/\/doi.org\/10.1038\/s44321-025-00293-5","relation":{},"ISSN":["1757-4676","1757-4684"],"issn-type":[{"value":"1757-4676","type":"print"},{"value":"1757-4684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,2]]},"assertion":[{"value":"5 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure and competing interests statement"}}],"article-number":"5"}}